Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010 | BMJ Open

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

This article has a correction. Please see:

Correction - March 01, 2014

PDF +
Supplementary
Material

XML

Epidemiology

Research

Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Ehrenstein V, Hernandez RK, Ulrichsen SP, et al

Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010

BMJ Open 2013;3:e003424. doi: 10.1136/bmjopen-2013-003424